FRUMIL furosemide (frusemide) 40 mg and amiloride hydrochloride dihydrate 5 mg tablets

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

furosemide, Quantity: 40 mg; amiloride hydrochloride dihydrate, Quantity: 5 mg

Disponibbli minn:

Sanofi-Aventis Australia Pty Ltd

INN (Isem Internazzjonali):

amiloride hydrochloride dihydrate,furosemide (frusemide)

Għamla farmaċewtika:

Tablet, uncoated

Kompożizzjoni:

Excipient Ingredients: microcrystalline cellulose; sodium starch glycollate type A; maize starch; sunset yellow FCF; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; purified talc

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

28

Tip ta 'preskrizzjoni:

(S1) This Schedule is intentionally blank

Indikazzjonijiet terapewtiċi:

FRUMIL is indicated for the treatment of cardiac failure, in patients who require diuretics plus potassium supplements, or potassium sparing diuretics.

Sommarju tal-prodott:

Visual Identification: Orange tablets with breakline; FRUMIL on reverse side.; Container Type: Blister Pack; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2007-08-20